Welcome to San Diego Biotech Networks DAILY for 12/18/2025. Daily news and jobs for are listed below. Please forward this email to your colleagues so they can subscribe at biotechnetworks.org/daily

​​​​​​​

Click a link below to view the mailing archive as if it had been sent to you.

2023-06-30 01:30SDBN News Daily: 4 New Articles
2023-06-29 01:30SDBN News Daily: 6 New Articles
2023-06-28 01:30SDBN News Daily: 6 New Articles
2023-06-27 01:30SDBN News Daily: 13 New Articles
2023-06-26 01:30SDBN News Daily: 2 New Articles
2023-06-25 01:30SDBN News Daily: 3 New Articles
2023-06-24 01:30SDBN News Daily: 15 New Articles
2023-06-23 01:30SDBN News Daily: 5 New Articles
2023-06-22 01:30SDBN News Daily: 7 New Articles
2023-06-21 01:30SDBN News Daily: 14 New Articles
2023-06-20 01:30SDBN News Daily: 3 New Articles
2023-06-18 01:30Moderna doubles down on rare diseases; FDA advisory committee votes on fall Covid campaign; Illumina CEO steps down; and more
2023-06-17 01:30SDBN News Daily: 7 New Articles
2023-06-16 01:30SDBN News Daily: 11 New Articles
2023-06-15 01:30SDBN News Daily: 11 New Articles
2023-06-14 01:30SDBN News Daily: 8 New Articles
2023-06-13 01:30SDBN News Daily: 11 New Articles
2023-06-12 01:30SDBN News Daily: 5 New Articles
2023-06-11 01:30Adcomm votes yes on Leqembi full OK; Merck brings first IRA lawsuit; Special: LGBTQ+ leaders; Best-paying biopharma jobs; and more
2023-06-10 01:30Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 Congress
2023-06-09 01:30SDBN News Daily: 19 New Articles
2023-06-08 01:30SDBN News Daily: 10 New Articles
2023-06-07 01:30SDBN News Daily: 7 New Articles
2023-06-06 01:30SDBN News Daily: 13 New Articles
2023-06-04 01:30Cross-border ‘twinning programs’ may reduce survival disparities for childhood leukemia
2023-06-03 01:30SDBN News Daily: 6 New Articles
2023-06-02 01:30SDBN News Daily: 14 New Articles
2023-06-01 01:30SDBN News Daily: 11 New Articles

 

<< Archive IndexSubscribe >>

© Biotech Networks. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.